MOTS-c
Mitochondrial-derived peptide. The exercise mimetic that optimizes metabolism, insulin sensitivity, and longevity.
Last updated: May 2026
Category
Longevity & Energy
Frequency
3–5x weekly
Research
Phase 1 Clinical TrialsWhat is MOTS-c?
MOTS-c (Mitochondrial Open reading frame of the 12S rRNA type-c) is a peptide encoded within the mitochondrial genome, making it one of the few known mitochondria-derived peptides. It was discovered in 2015 and is a subject of intense longevity research for its role in metabolic regulation and stress resistance. Browse the full peptide library for related longevity compounds.
MOTS-c is often called an 'exercise mimetic' because it activates many of the same cellular pathways that are triggered by physical exercise, including AMPK activation, improved insulin sensitivity, and mitochondrial biogenesis. For cellular energy support, it stacks well with NAD+. Studies in elderly mice showed dramatic improvements in exercise capacity and metabolism when given MOTS-c.
What makes MOTS-c uniquely interesting for longevity is that it is a retrograde signal from the mitochondria (the powerhouses of the cell) to the nucleus, a form of cellular communication that declines with age. For telomere extension, consider combining with Epitalon. Supplementing MOTS-c may help restore this critical signaling pathway. Longevity stacks often combine MOTS-c with thymosin alpha-1 to address both metabolic and immune aspects of aging.
How It Works
AMPK Activation: MOTS-c activates AMPK (AMP-activated protein kinase), the master metabolic sensor of the cell. AMPK activation improves insulin sensitivity, promotes fat oxidation, and mimics the effects of caloric restriction.
FOXO Pathway: MOTS-c activates FOXO transcription factors, which regulate longevity genes and stress resistance pathways.
Mitochondrial Biogenesis: MOTS-c promotes the formation of new mitochondria, improving cellular energy capacity and metabolic efficiency.
Nuclear Translocation: Uniquely, MOTS-c can translocate from the mitochondria to the cell nucleus during stress, where it directly regulates gene expression.
Benefits
- Improved insulin sensitivity and blood glucose regulation
- Enhanced fat oxidation and metabolic efficiency
- Exercise mimetic effects (activates exercise pathways)
- Improved muscle endurance and physical performance
- Longevity pathway activation (AMPK, FOXO)
- Potential obesity prevention
- Anti-inflammatory effects
- Neuroprotective properties
Dosing Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Standard | 5mg | 3–5x weekly SC | 8 weeks |
| Cycle | 5mg | 3x weekly | 8 weeks on, 4 off |
Always start at the lowest effective dose and titrate up gradually.
Side Effects
Common
- ⚠Generally very well tolerated in studies
- ⚠Mild injection site reaction
- ⚠Possible increased appetite (metabolic activation)
Rare
- •Hypoglycemia in fasted state at high doses
Who Should NOT Use MOTS-c
- ✕Type 1 diabetes (monitor blood sugar carefully)
- ✕Pregnancy or breastfeeding
- ✕Active cancer (insufficient safety data)
What to Expect
Improved energy and endurance during exercise. Blood sugar levels may stabilize.
Noticeable metabolic improvements. Better body composition. Improved exercise recovery.
Full metabolic benefits realized. Stacks well with caloric restriction or fasting protocols.
Notes from Ho Chi Minh City
MOTS-c is the peptide where my fasted glucose readings on a CGM made the case more clearly than how I actually felt. I started a Monday/Wednesday/Friday 5mg subcutaneous protocol while training jiu-jitsu six days a week in Binh Thanh, and after 4 weeks my morning fasted glucose dropped from a 95 to 99 average down to 82 to 86, and my time-in-range during meals improved as well. The subjective effect was modest, just slightly better endurance in long rolls and slightly less crash after lunch, but the metabolic data was unambiguous. Storage matters in this climate; the lyophilized vial holds up but reconstituted MOTS-c needs to stay in the door of the fridge, not the freezer, and used within 21 days.
FAQ
Q: Can MOTS-c replace exercise?
A: No, it is an exercise mimetic, meaning it activates some of the same pathways as exercise. But exercise has many more effects beyond metabolic signaling. MOTS-c is a complement to, not a replacement for, physical activity.
Q: How does MOTS-c differ from NAD+?
A: Both support mitochondrial function but through different mechanisms. NAD+ provides the fuel (electron carrier). MOTS-c sends the signaling message from mitochondria to the nucleus. They are complementary and commonly stacked. Source from the community-verified supplier list. For clinics and protocols specific to Vietnam, see the NAD+ therapy guide.
Where to Get MOTS-c in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.
Related Peptides
Research & Sources
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Lee C, Zeng J, Drew BG, et al. · Cell Metabolism (2015) PMID: 25738459
Original discovery paper showing AMPK activation and metabolic effects in mouse models.
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis · Reynolds JC, Lai RW, Woodhead JST, et al. · Nature Communications (2021) PMID: 33500411
Demonstrates exercise-mimetic actions and improvements in exercise capacity in aged mice.
- Mitochondrial-derived peptides in aging and age-related diseases · Miller B, Kim SJ, Kumagai H, Yen K, Cohen P · GeroScience (2022) PMID: 34292502
Reviews MOTS-c, humanin, and SHLP family in the context of longevity and metabolic disease, including FOXO pathway and muscle insulin sensitivity mechanisms.
Important Disclaimer
Educational content only. Not medical advice. Peptides discussed on this page are not approved by Vietnam’s Ministry of Health (Bộ Y Tế) or the Drug Administration of Vietnam (DAV) for the indications described. Research peptides are not stocked at Long Châu, Pharmacity, or any retail pharmacy in Vietnam. Consult a licensed physician before any use.